WallStreetZenWallStreetZen

NASDAQ: MBIO
Mustang Bio Inc Stock

$0.94+0.01 (+1.08%)
Updated Mar 27, 2024
MBIO Price
$0.94
Fair Value Price
$0.43
Market Cap
$9.77M
52 Week Low
$0.90
52 Week High
$8.17
P/E
-0.16x
P/B
79.4x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$51.60M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
143.24
Operating Cash Flow
-$49M
Beta
1.5
Next Earnings
May 10, 2024
Ex-Dividend
N/A
Next Dividend
N/A

MBIO Overview

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-107 and MB-207, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-102 CAR T therapies for blastic plasmacytoid dendritic cell neoplasm, acute myeloid leukemia, and myelodysplastic syndrome; MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-104 CAR T for multiple myeloma and light chain amyloidosis; MB-101 CAR T cell program for glioblastoma; MB-103 CAR T for glioblastoma multiforme (GBM) and metastatic breast cancer to brain; MB-105 CAR T for prostate and pancreatic cancers; and MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clin Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH, and Minaris Regenerative Medicine GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts.

Zen Score

–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MBIO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MBIO ($0.94) is overvalued by 116.48% relative to our estimate of its Fair Value price of $0.43 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
MBIO ($0.94) is not significantly undervalued (116.48%) relative to our estimate of its Fair Value price of $0.43 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
MBIO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MBIO due diligence checks available for Premium users.

Be the first to know about important MBIO news, forecast changes, insider trades & much more!

MBIO News

Valuation

MBIO fair value

Fair Value of MBIO stock based on Discounted Cash Flow (DCF)
Price
$0.94
Fair Value
$0.43
Overvalued by
116.48%
MBIO ($0.94) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MBIO ($0.94) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MBIO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MBIO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.16x
Industry
14.3x
Market
44.45x

MBIO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
79.4x
Industry
6.2x
MBIO is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MBIO's financial health

Profit margin

Revenue
$0.0
Net Income
-$8.6M
Profit Margin
0%
MBIO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$17.7M
Liabilities
$17.6M
Debt to equity
143.24
MBIO's short-term liabilities ($15.37M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MBIO's short-term assets ($11.35M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MBIO's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MBIO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$7.3M
Investing
-$30.0k
Financing
$4.0M
MBIO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MBIO vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
MBIO$9.77M+0.97%-0.16x79.40x
AEZS$10.10M+4.00%-0.61x0.56x
ONVO$10.14M-3.81%-0.47x1.64x
VIRI$9.32M+12.56%-1.73x2.45x
CVKD$10.25M-1.39%-1.03x1.33x

Mustang Bio Stock FAQ

What is Mustang Bio's quote symbol?

(NASDAQ: MBIO) Mustang Bio trades on the NASDAQ under the ticker symbol MBIO. Mustang Bio stock quotes can also be displayed as NASDAQ: MBIO.

If you're new to stock investing, here's how to buy Mustang Bio stock.

What is the 52 week high and low for Mustang Bio (NASDAQ: MBIO)?

(NASDAQ: MBIO) Mustang Bio's 52-week high was $8.17, and its 52-week low was $0.90. It is currently -88.49% from its 52-week high and 4.44% from its 52-week low.

How much is Mustang Bio stock worth today?

(NASDAQ: MBIO) Mustang Bio currently has 10,390,132 outstanding shares. With Mustang Bio stock trading at $0.94 per share, the total value of Mustang Bio stock (market capitalization) is $9.77M.

Mustang Bio stock was originally listed at a price of $147.00 in Aug 22, 2017. If you had invested in Mustang Bio stock at $147.00, your return over the last 6 years would have been -99.36%, for an annualized return of -56.92% (not including any dividends or dividend reinvestments).

How much is Mustang Bio's stock price per share?

(NASDAQ: MBIO) Mustang Bio stock price per share is $0.94 today (as of Mar 27, 2024).

What is Mustang Bio's Market Cap?

(NASDAQ: MBIO) Mustang Bio's market cap is $9.77M, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Mustang Bio's market cap is calculated by multiplying MBIO's current stock price of $0.94 by MBIO's total outstanding shares of 10,390,132.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.